Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study

被引：0
|
作者：
Yan-Ming Zeng
Yao Li
Yan-Qiu Lu
Min Liu
Jing-Min Nie
Jing Yuan
Vijay Harypursat
Yi-Hong Zhou
Yuan-Yuan Qin
Xiao-Hong Chen
Yu-Lin Zhang
De-Fa Zhang
Ni Wang
Hui Chen
Qun Tian
Yang Zhou
Ying-Mei Qin
Xin-Ping Yang
Yao-Kai Chen
机构：
[1] Chongqing Public Health Medical Center,Division of Infectious Diseases
[2] The Fourth Affiliated Hospital of Harbin Medical University,Department of Infectious Diseases
[3] Capital Medical University,Division of Infectious Diseases, Beijing Youan Hospital
[4] Nankai University,Department of Infectious Diseases, Tianjin Second People’s Hospital
[5] Capital Medical University,School of Biomedical Engineering
[6] The Third People’s Hospital of Guilin,Division of Infectious Disease
[7] Shenzhen Third People’s Hospital,Division of Infectious Diseases
[8] The Fourth People’s Hospital of Nanning,Division of Infectious Diseases
[9] Yunnan Provincial Infectious Disease Hospital,Division of Infectious Disease
来源：
BMC Pulmonary Medicine | / 22卷
关键词：
HIV; Pneumocystis pneumonia; Antiretroviral therapy; Initiation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 3 条
  • [1] Initiating antiretroviral therapy within 2 weeks of anti-Pneumocystis treatment does not increase mortality or AIDS-defining events in patients with HIV-associated moderate to severe Pneumocystis pneumonia: results of a prospective observational multicenter study
    Zeng, Yan-Ming
    Li, Yao
    Lu, Yan-Qiu
    Liu, Min
    Nie, Jing-Min
    Yuan, Jing
    Harypursat, Vijay
    Zhou, Yi-Hong
    Qin, Yuan-Yuan
    Chen, Xiao-Hong
    Zhang, Yu-Lin
    Zhang, De-Fa
    Wang, Ni
    Chen, Hui
    Tian, Qun
    Zhou, Yang
    Qin, Ying-Mei
    Yang, Xin-Ping
    Chen, Yao-Kai
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [2] Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)
    Guido Schäfer
    Christian Hoffmann
    Keikawus Arasteh
    Dirk Schürmann
    Christoph Stephan
    Björn Jensen
    Matthias Stoll
    Johannes R. Bogner
    Gerd Faetkenheuer
    Jürgen Rockstroh
    Hartwig Klinker
    Georg Härter
    Albrecht Stöhr
    Olaf Degen
    Eric Freiwald
    Anja Hüfner
    Sabine Jordan
    Julian Schulze zur Wiesch
    Marylyn Addo
    Ansgar W. Lohse
    Jan van Lunzen
    Stefan Schmiedel
    AIDS Research and Therapy, 16
  • [3] Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)
    Schaefer, Guido
    Hoffmann, Christian
    Arasteh, Keikawus
    Schuermann, Dirk
    Stephan, Christoph
    Jensen, Bjoern
    Stoll, Matthias
    Bogner, Johannes R.
    Faetkenheuer, Gerd
    Rockstroh, Juergen
    Klinker, Hartwig
    Haerter, Georg
    Stoehr, Albrecht
    Degen, Olaf
    Freiwald, Eric
    Huefner, Anja
    Jordan, Sabine
    Zur Wiesch, Julian Schulze
    Addo, Marylyn
    Lohse, Ansgar W.
    van Lunzen, Jan
    Schmiedel, Stefan
    AIDS RESEARCH AND THERAPY, 2019, 16 (01)
1